Search for: "APOTEX CORP."
Results 161 - 180
of 333
Sorted by Relevance
|
Sort by Date
8 Oct 2013, 2:52 pm
Apotex Inc., 687 F.3d 1362, 1367 (Fed. [read post]
23 Sep 2016, 7:12 am
Apotex Corp., 782F.3d 1324, 1333 (Fed. [read post]
14 Dec 2006, 4:08 am
Apotex Corp., C.A. [read post]
22 Dec 2010, 3:01 am
Corp. of Am. [read post]
15 Jun 2011, 4:56 am
Apotex Inc. [read post]
20 Dec 2011, 7:41 am
Research Corp v. [read post]
5 May 2010, 4:46 am
Second Circuit invites further review in Cipro patent settlement case (FDA Law Blog) Concerta (Methylphenidate) – US: CAFC affirms invalidity of Concerta patent for lack of enablement: ALZA Corp. v Andrz Pharms. [read post]
25 Mar 2024, 4:36 am
Interchemical Corp., 325 U.S. 327 (1945) (obvious because “not the product of long and difficult experimentation” rather by “selecting a known compound to meet known requirements. [read post]
3 Nov 2014, 9:48 am
The district court rejected defendants’ attempt to invoke the primary jurisdiction doctrine noting that there was no special expertise necessary to determine whether or not the FDA has approved a particular drug. [8] Id. at *9 [9] Id. [10] Apotex Inc. and Apotex Corp. v. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US:… [read post]
14 May 2015, 4:00 am
NOVA Chemicals Corp 2014 FC 844 Justice O’Keefe found there was no explicit Promise for a specific result, such that a “mere scintilla” of utility was sufficient for Dows’ polymer patent. [read post]
12 Apr 2017, 9:52 am
Patent No.8,324,283 (the ’283 patent), owned by Novartis AG andMistubishi Tanabe Pharma Corp. [read post]
21 Oct 2019, 5:00 am
Apotex Corp also issued a precautionary recall. [read post]
20 May 2011, 4:01 pm
Tokai Corp. v. [read post]
25 May 2012, 11:32 am
Apotex Corp., 669 F.3d 1370 (Fed. [read post]
13 Oct 2011, 7:45 pm
Apotex, Inc., 470 F.3d 1368, 1374 (Fed. [read post]
15 Sep 2009, 10:54 pm
Apotex Corp., 439 F.3d 1312, 1317 (Fed. [read post]
25 Jun 2015, 5:00 am
See In re Schering-Plough Corp. [read post]
11 Jun 2007, 8:03 am
Apotex, 06-1582, involves a dispute over patent claims for a medicine for treating high blood pressure. [read post]
14 Jul 2010, 6:47 pm
Boehringer Ingelheim Pharma (EPLAW) Plavix (Clopidogrel) – US: Apotex’s second request for re-examination of Plavix patent denied by USPTO (Patent Docs) Tarka (Trandolapril, Verapamil) – Sanofi, Abbott successfully request sanctions against Glenmark in Tarka dispute (Patent Docs) [read post]
